Rosalind Franklin University Secures $1.9M NIH Grant for Neurological Disease Research

Event summary

  • Rosalind Franklin University (RFU) researcher Hongkyun Kim, PhD, received a $1.9M NIH grant for 5-year research on CaV2 voltage-gated calcium channels.
  • The grant funds studies on synaptic transmission proteins linked to neurological disorders like epilepsies, migraines, and pain.
  • Dr. Kim will use C. elegans as a model organism to identify molecular components affecting calcium channel abundance.
  • RFU's executive vice president for research, Joseph DiMario, PhD, highlighted Dr. Kim's expertise in neurological disorders.

The big picture

The $1.9M NIH grant underscores the strategic importance of RFU's research in neurological disorders, particularly in understanding synaptic transmission proteins. This funding aligns with broader industry trends toward targeted therapies for neurological diseases, positioning RFU as a key player in biomedical research. The grant's scale highlights the growing investment in neuroscience, reflecting its critical role in addressing prevalent health challenges.

What we're watching

Research Impact
How the findings on CaV2 voltage-gated calcium channels will advance treatments for neurological disorders.
Funding Utilization
The pace at which the $1.9M grant will be allocated and its effect on RFU's research capabilities.
Industry Collaboration
Whether RFU can leverage this grant to form new partnerships in neurological disease research.

Related topics

Biotechnology